Analytical strategies based on mass spectrometric techniques for the study of steroid metabolism

TrAC - Trends in Analytical Chemistry

Volumn 53, Issue , 2014, Pages 106-116

  Gomez, Cristina ^a   Fabregat, Andreu ^a   Pozo, Óscar J ^a   Marcos, Josep ^a,b   Segura, Jordi ^a,b   Ventura, Rosa ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Anabolic androgenic steroid (AAS); Analytical strategy; Doping analysis; Forbidden substance; Glucuronide; Mass spectrometry (MS); Metabolism; Sample preparation; Steroid; Sulfate

Indexed keywords

MASS SPECTROMETRY; METABOLISM;

ANABOLIC ANDROGENIC STEROID (AAS); ANALYTICAL STRATEGY; DOPING ANALYSIS; FORBIDDEN SUBSTANCE; GLUCURONIDES; SAMPLE PREPARATION; STEROID; SULFATE;

PHYSIOLOGY;

ACETYLCYSTEINE; ANABOLIC AGENT; ANDROGEN; CYSTEINE;

CHEMICAL STRUCTURE; DERIVATIZATION; DOPING; ELECTROSPRAY MASS SPECTROMETRY; HYDROLYSIS; IONIZATION; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOLID PHASE EXTRACTION; STEROID METABOLISM; TANDEM MASS SPECTROMETRY;

EID: 84888266436     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2013.08.010     Document Type: Review

References (74)

1. World Anti-Doping Agency (WADA) 2011 Laboratory Testing Figures. <>. http://www.wada-ama.org/Documents/Resources/Testing-Figures/WADA-2011-Laboratory-Testing-Figures.pdf.
2. Schänzer W. Metabolism of anabolic androgenic steroids. Clin. Chem. 1996, 42:1001-1020.
3. Van Eenoo P., Delbeke F.T. Metabolism and excretion of anabolic steroids in doping control: new steroids and new insights. J. Steroid Biochem. Mol. Biol. 2006, 101:161-178.
4. Schänzer W., Donike M. Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolites. Anal. Chim. Acta 1993, 275:23-48.
5. Pozo O.J., Van Eenoo P., Deventer K., Delbeke F.T. Detection and characterization of anabolic steroids in doping analysis by LC-MS. Trends Anal. Chem. 2008, 27:657-671.
6. Pozo O.J., Marcos J., Segura J., Ventura R. Recent developments in MS for small molecules: application to human doping control analysis. Bioanalysis 2012, 4:197-212.
7. Ojanpera I., Kolmonen M., Palander A. Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control. Anal. Bioanal. Chem. 2012, 403:1203-1220.
8. Soldin S.J., Soldin O.P. Steroid hormone analysis by tandem mass spectrometry. Clin. Chem. 2009, 55:1061-1066.
9. Gosetti F., Mazzucco E., Gennaro M.C., Marengo E. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review. J. Chromatogr. B 2013, 927:22-36.
10. Pozo O.J., Gómez C., Marcos J., Segura J., Ventura R. Detection and characterization of urinary metabolites of boldione by LC-MS/MS. Part II: Conjugates with cysteine and N-acetylcysteine. Drug Test. Anal. 2012, 4:786-797.
11. Fabregat A., Kotronoulas A., Marcos J., Joglar J., Alfonso I., Segura J., Ventura R., Pozo O.J. Detection, synthesis and characterization of metabolites of steroid hormones conjugated with cysteine. Steroids 2013, 78:327-336.
12. Gómez C., Pozo O.J., Marcos J., Segura J., Ventura R. Alternative long-term markers for the detection of methyltestosterone misuse. Steroids 2013, 78:44-52.
13. Lootens L., Meuleman P., Pozo O.J., Van Eenoo P., Leroux-Roels G., Delbeke F.T. UPA+/+-SCID mouse with humanized liver as a model for in vivo metabolism of exogenous steroids: methandienone as a case study. Clin. Chem. 2009, 55:1783-1793.
14. Pozo O.J., Lootens L., Van Eenoo P., Deventer K., Meuleman P., Leroux-Roels G., Parr M.K., Schänzer W., Delbeke F.T. Combination of liquid-chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism. Drug Test. Anal. 2009, 1:554-567.
15. Pozo O.J., Van Eenoo P., Deventer K., Lootens L., Van Thuyne W., Parr M.K., Schänzer W., Sancho J.V., Hernández F., Meuleman P., Leroux-Roels G., Delbeke F.T. Detection and characterization of a new metabolite of 17alpha-methyltestosterone. Drug Metab. Dispos. 2009, 37:2153-2162.
16. Pozo O.J., Van Eenoo P., Deventer K., Lootens L., Grimalt S., Sancho J.V., Hernández F., Meuleman P., Leroux-Roels G., Delbeke F.T. Detection and structural investigation of metabolites of stanozolol in human urine by liquid chromatography tandem mass spectrometry. Steroids 2009, 74:837-852.
17. Lootens L., Meuleman P., Leroux-Roels G., Van Eenoo P. Metabolic studies with promagnon, methylclostebol and methasterone in the uPA(+/+)-SCID chimeric mice. J. Steroid Biochem. Mol. Biol. 2011, 127:374-381.
18. Schänzer W. Sports. Drug Abuse Handbook 1998, 697-722. CRC, Boca Raton. S.B. Karch (Ed.).
19. Massé R., Ayotte C., Dugal R. Studies on anabolic steroids. I. Integrated methodological approach to the gas chromatographic-mass spectrometric analysis of anabolic steroid metabolites in urine. J. Chromatogr. Biomed. Appl. 1989, 489:23-50.
20. Ahi S., Reddy I.M., Beotra A., Lal R., Jain S., Kaur T. Sample purification procedure for confirmation of 3'-hydroxy stanozolol by gas chromatography/high resolution mass spectrometry. Indian J. Pharmacol. 2008, 40:164-169.
21. Saito K., Yagi K., Ishizaki A., Kataoka H. Determination of anabolic steroids in human urine by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 2010, 52:727-733.
22. Parr M.K., Kazlauskas R., Schlörer N., Opfermann G., Piper T., Schulze G., Schänzer W. 6α-Methylandrostenedione: gas chromatographic mass spectrometric detection in doping control. Rapid Commun. Mass Spectrom. 2008, 22:321-329.
23. Donike M., Zimmermann J. Peparation of trimethylsilyl, triethylsilyl and tert-butyldimethylsilyl enol ethers from ketosteroids for investigations by gas-chromatography and mass spectrometry analysis. J. Chromatogr. 1980, 202:483.
24. Hewitt S.A., Kearney M., Currie J.W. Screening and confirmatory strategies for the surveillance of anabolic steroid abuse within Northern Ireland, P.B. Young, D.G. Kennedy. Anal. Chim. Acta 2002, 473:99-109.
25. Shackleton C.H. Profiling steroid hormones and urinary steroids. J. Chromatogr. 1986, 379:91-156.
26. Athanasiadou I., Angelis Y.S., Lyris E., Georgakopoulos C. Chemical derivatization to enhance ionization of anabolic steroids in LC-MS for doping-control analysis. Trends Anal. Chem. 2013, 42:137-156.
27. Budzikiewicz H., Djerassi C. Mass spectrometry in structural and stereochemical problems. I. Steroid ketones. J. Am. Chem. Soc. 1962, 84:1430-1439.
28. Ward R.J., Shackleton C.H. Gas chromatographic - mass spectrometric methods for the detection and identification of anabolic steroid drugs, A.M. Lawson. Br. J. Sports Med. 1975, 9:93-97.
29. Thevis M., Schänzer W. Mass spectrometry in sports drug testing: structure characterization and analytical assays. Mass Spectrom. Rev. 2007, 26:79-107.
30. Hintikka L., Haapala M., Franssila S., Kuuranne T., Leinonen A., Kostiainen R. Feasibility of gas chromatography-microchip atmospheric pressure photoionization-mass spectrometry in analysis of anabolic steroids. J. Chromatogr. A 2010, 1217:8290-8297.
31. Zhang Y., Tobias H.J., Brenna J.T. Highly sensitive and selective analysis of urinary steroids by comprehensive two-dimensional gas chromatography combined with positive chemical ionization quadrupole mass spectrometry. Analyst 2012, 137:3102-3110.
32. Sobolevsky T., Rodchenkov G. Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control. Drug Test. Anal. 2012, 4:682-691.
33. Sobolevsky T., Rodchenkov G. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J. Steroid. Biochem. Mol. Biol. 2012, 128:121-127.
34. Cavalcanti G.de A., Leal F.D., Garrido B.C., Padilha M.C., Neto F.R. Detection of designer steroid methylstenbolone in "nutritional supplement" using gas chromatography and tandem mass spectrometry: elucidation of its urinary metabolites. Steroids 2013, 78:228-233.
35. Parr M.K., Fusshöler G., Gütschow M., Hess C., Schänzer W. Recent Advances in Doping Analysis (18) Proceedings of the Manfred Donike Workshop 28th Cologne Workshop on Dope Analysis 2010, Sportverlag Strauss, Köln, 64.
36. Fragkaki A.G., Angelis Y.S., Tsantili-Kakoulidou A., Koupparis M., Georgakopoulos C. Schemes of metabolic patterns of anabolic androgenic steroids for the estimation of metabolites of designer steroids in human urine. J. Steroid Biochem. Mol. Biol. 2009, 115:44-61.
37. Revelsky A.I., Samokhin A.S., Virus E.D., Rodchenkov G.M., Revelsky I.A. High sensitive analysis of steroids in doping control using gas chromatography/time-of-flight mass-spectrometry. Drug Test. Anal. 2011, 3:263.
38. Pozo O.J., Van Eenoo P., Deventer K., Delbeke F.T. Ionization of anabolic steroids by adduct formation in liquid chromatography electrospray mass spectrometry. J. Mass Spectrom. 2007, 42:497-516.
39. Ahonen L.L., Haapala M., Saarela V., Franssila S., Kotiaho T., Kostiainen R. Feasibility of capillary liquid chromatography/microchip atmospheric pressure photoionization mass spectrometry in analyzing anabolic steroids in urine samples. Rapid Commun. Mass Spectrom. 2010, 42:958-964.
40. Marwah A., Marwah P., Lardy H. Analysis of ergosteroids. VIII: Enhancement of signal response of neutral steroidal compounds in liquid chromatographic-electrospray ionization mass spectrometric analysis by mobile phase additives. J. Chromatogr. A 2002, 964:137-151.
41. Rannulu N.S., Cole R.B. Novel fragmentation pathways of anionic adducts of steroids formed by electrospray anion attachment involving regioselective attachment, regiospecific decompositions, charge-induced pathways, and ion-dipole complex intermediates. J. Am. Soc. Mass Spectrom. 2012, 23:1558-1568.
42. Pozo O.J., VanEenoo P., Deventer K., Grimalt S., Sancho J.V., Hernández F., Delbeke F.T. Collision-induced dissociation of 3-keto anabolic steroids and related compounds after electrospray ionization. Considerations for structural elucidation. Rapid Commun. Mass Spectrom. 2008, 22:4009-4024.
43. Thevis M., Bommerich U., Opfermann G., Schänzer W. Characterization of chemically modified steroids for doping control purposes by electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 2005, 40:494-502.
44. Pozo O.J., Deventer K., Van Eenoo P., Delbeke F.T. Efficient approach for the comprehensive detection of unknown anabolic steroids and metabolites in human urine by liquid chromatography-electrospray-tandem mass spectrometry. Anal. Chem. 2008, 80:1709-1720.
45. Kim Y., Jun M., Lee W. Characterization of boldione and its metabolites in human urine by liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20:9-20.
46. Gómez C., Pozo O.J., Fabregat A., Marcos J., Deventer K., Van Eenoo P., Segura J., Ventura R. Detection and characterization of urinary metabolites of boldione by LC-MS/MS. Part I: Phase I metabolites excreted free, as glucuronide and sulfate conjugates, and released after alkaline treatment of the urine. Drug Test. Anal. 2012, 4:775-785.
47. Scarth J.P., Clarke A.D., Teale P., Pearce C.M. Comparative in vitro metabolism of the 'designer' steroid estra-4,9-diene-3,17-dione between the equine, canine and human: identification of target metabolites for use in sports doping control. Steroids 2010, 75:643-652.
48. Pozo O.J., Van Eenoo P., Deventer K., Elbardissy H., Grimalt S., Sancho J.V., Hernandez F., Ventura R., Delbeke F.T. Comparison between triple quadrupole, time of flight and hybrid quadrupole time of flight analysers coupled to liquid chromatography for the detection of anabolic steroids in doping control analysis. Anal. Chim. Acta 2011, 684:98-111.
49. Lu J., He G., Wang X., Xu Y., Wu Y., Dong Y., Liu X., He Z., Zhao J., Yuan H. Mass spectrometric identification and characterization of new fluoxymesterone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry. Steroids 2012, 77:871-877.
50. Peters R.J.B., Rijk J.C.W., Bovee T.F.H., Nijrolder A.W.J.M., Lommen A., Nielen M.W.F. Identification of anabolic steroids and derivatives using bioassay-guided fractionation, UHPLC/TOFMS analysis and accurate mass database searching. Anal. Chim. Acta 2010, 664:77-88.
51. Pozo O.J., Van Thuyne W., Deventer K., Van Eenoo P., Delbeke F.T. Elucidation of urinary metabolites of fluoxymesterone by liquid chromatography-tandem mass spectrometry and gas chromatography-mass spectrometry. J. Mass Spectrom. 2008, 43:394-408.
52. Gomes R.L., Meredith W., Snape C.E., Sephton M.A. Analysis of conjugated steroid androgens: deconjugation, derivatisation and associated issues. J. Pharm. Biomed. Anal. 2009, 49:1133-1140.
53. Wade A.P. Hydrolysis of pregnanediol glucuronide by sodium periodate. Biochem. J. 1967, 103:19C-20C.
54. Cooper J., Currie W., Elliott C.T. Comparison of the efficiences of enzymatic and chemical hydrolysis of (nortestosterone and diethylstilboestrol) glucuronides in bovine urine. J. Chromatogr. B. Biomed. Sci. Appl. 2001, 757:221-227.
55. Graef V., Furuya E., Nishikaze O. Hydrolysis of steroid glucuronides with beta-glucuronidase preparations from bovine liver, Helix pomatia, and E. coli. Clin. Chem. 1977, 23:532-535.
56. Schmidt N.A., Borburgh H.J., Penders T.J., Weykamp C.W. Steroid profiling - an update. Clin. Chem. 1985, 31:637-639.
57. Makin H.L.J., Honour W.J., Shackleton C.H., Griffiths J. General methods for the exraction, purification and measurement of steroids by chromatography and mass spectrometry. Steroid Analysis 2010, 163-282. Springer, London. H.L.J. Makin, D.B. Gower (Eds.).
58. Fabregat A., Pozo O.J., Marcos J., Segura J., Ventura R. Use of LC-MS/MS for the open detection of steroid metabolites conjugated with glucuronic acid. Anal. Chem. 2013, 85:5005-5014.
59. Kuuranne T., Kotiaho T., Pedersen-Bjergraad S., Rasmussen K.E., Leinonen A., Westwood S., Kostiainen R. Feasibility of a liquid-phase microextraction sample clean-up and liquid chromatographic/mass spectrometric screening method for selected anabolic steroid glucuronides in biological samples. J. Mass Spectrom. 2003, 38:16-26.
60. Bean K.A., Henion J.D. Direct determination of anabolic steroid conjugates in human urine by combined high-performance liquid chromatography and tandem mass spectrometry. J. Chromatogr. B 1997, 690:65-75.
61. Saudan C., Entenza J.M., Baume N., Mangin P., Saugy M. Short-term stability of testosterone and epitestosterone conjugates in urine samples: quantification by liquid chromatography-linear ion trap mass spectrometry. J. Chromatogr. B 2006, 844:168-174.
62. Borts D.J., Bowers L.D. Direct measurement of urinary testosterone and epitestosterone conjugates using high-performance liquid chromatography/tandem mass spectrometry. J. Mass Spectrom. 2000, 35:50-61.
63. Buiarelli F., Giannetti L., Jasionowska R., Cruciani C., Neri B. Determination of nandrolone metabolites in human urine: comparison between liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 2010, 24:1881-1894.
64. Antignac J.P., Brosseaud A., Gaudin-Hirret I., André F., Le Bizec B. Analytical strategies for the direct mass spectrometric analysis of steroid and corticosteroid phase II metabolites. Steroids 2005, 70:205-216.
65. Gómez C., Pozo O.J., Geyer H., Marcos J., Thevis M., Schänzer W., Segura J., Ventura R. New potential markers for the detection of boldenone misuse. J. Steroid Biochem. Mol. Biol. 2012, 132:239-246.
66. Bowers L.D., Sanaullah Direct measurement of steroid sulfate and glucuronide conjugates with high-performance liquid chromatography-mass spectrometry. J. Chromatogr. B 1996, 687:61-68.
67. Yi L., Dratter J., Wang C., Tunge J.A., Desaire H. Identification of sulfation sites of metabolites and prediction of the compounds' biological effects. Anal. Bioanal. Chem. 2006, 386:666-674.
68. Pozo O.J., Marcos J., Ventura R., Fabregat A., Segura J. Testosterone metabolism revisited: discovery of new metabolites. Anal. Bioanal. Chem. 2010, 398:1759-1770.
69. Murai T., Iwabuchi H., Ikeda T. Repeated glucuronidation at one hydroxyl group leads to structurally novel diglucuronides of steroid sex hormones. Drug Metab. Pharmacokinet. 2005, 20:282-293.
70. Argikar A. Unusual glucuronides. Drug Metab. Dispos. 2012, 40:1239-1251.
71. Domínguez-Romero J.C., Garcia-Reyes J.F., Martínez-Romero R., Martínez-Lara E., Del Moral-Leal M.L., Molina-Díaz A. Detection of main urinary metabolites of beta(2)-agonists clenbuterol, salbutamol and terbutaline by liquid chromatography high resolution mass spectrometry. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2013, 923:128-135.
72. Anizan S., Bichon E., Di Nardo D., Monteau F., Cesbron N., Antignac J.P., Le Bizec B. Screening of 4-androstenedione misuse in cattle by LC-MS/MS profiling of glucuronide and sulfate steroids in urine. Talanta 2011, 86:186-194.
73. Mitreveski B.S., Wilairat P., Marriott P.J. Comprehensive two-dimensional gas chromatography improves separation and identification of anabolic agents in doping control. J. Chromatogr. A 2010, 1217:127-135.
74. Boccard J., Badoud F., Grata E., Quertani S., Hanati M., Mazerolles G., Lanten P., Veuthey J.L., Saugy M., Rudaz S. A steroidomic approach for biomarkers discovery in doping control. Forensic Sci. Int. 2011, 213:85-94.